TY  - GEN
AU  - Koda,R T
AU  - Garcia,A A
AU  - Chatterjee,D J
AU  - Li,W Y
AU  - Parimoo,D
AU  - Jeffers,S
AU  - Rogers,M
AU  - Leichman,C G
AU  - Leichman,L
AU  - Wu,E Y
AU  - Shetty,B V
AU  - Webber,S
AU  - Clendinnin,N
AU  - Muggia,F M
TI  - Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors
SN  - 0344-5704
PY  - 1999///0520
KW  - Adult
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - adverse effects
KW  - Dose-Response Relationship, Drug
KW  - Enzyme Inhibitors
KW  - Female
KW  - Half-Life
KW  - Humans
KW  - Indoles
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Thymidylate Synthase
KW  - antagonists & inhibitors
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s002800050928
ER  -